Know someone who's been diagnosed with breast cancer? There's a good chance that person has received hormone therapy. Estrogen receptor-positive (ER+) breast cancers account for about 75% of cases. Hormone therapy is one ...
Oct 21, 2025
0
25
Adults with gum disease may be more likely to have signs of damage to the brain's white matter, called white matter hyperintensities, than people without gum disease, according to a study published in Neurology Open Access.
Oct 22, 2025
0
3
Researchers have created a new type of drug molecule that can precisely destroy TERRA, an RNA molecule that helps certain cancer cells survive. Using advanced "RIBOTAC" technology, their compound finds TERRA inside cells ...
Oct 23, 2025
0
0
Stillbirths occur at a higher rate in the U.S. than previously reported, according to a new study led by researchers at Harvard T.H. Chan School of Public Health and Mass General Brigham.
18 hours ago
0
18
Researchers from UNIGE and Marburg show that D-cysteine, the "mirror" form of cysteine, selectively targets certain cancer cells.
13 hours ago
0
48
Immunotherapy has been one of the most promising advancements in cancer treatment. However, consistency in immunotherapy treatment effectiveness remains a formidable challenge. Now, Cancer Center at Illinois member Kun Wang, ...
Oct 22, 2025
0
27
Teens and young adults who use cannabis are more likely to become regular tobacco users—even if they haven't previously tried tobacco—compared to similar people who do not use cannabis, suggests a US study published online ...
Oct 23, 2025
0
0
Swiss pharmaceutical giant Novartis announced Sunday it had agreed to buy Avidity Biosciences, valuing the US biopharmaceutical company at $12 billion.
23 hours ago
0
1
Arc Institute, Gladstone Institutes, and University of California, San Francisco, scientists have developed an epigenetic editing platform that enables safe modification of multiple genes in primary human T cells, addressing ...
Oct 21, 2025
0
30
Copenhagen University Hospital–Herlev and Gentofte led a nationwide registry study that the authors claim shows a "pattern suggesting" a lower five-year risk of any first cancer (excluding non-melanoma skin cancer) with ...
